BIOMAT Database Logo BIOMAT Database Logo

Importance of HLA-DRB1 genotyping in cadaveric renal transplantation. 1992

M Sada, and M Hashimoto, and Y Ichikawa, and T Kaneshige, and S Nakamura, and S Suzuki, and K Uchida, and T Fukunishi, and H Amemiya
Department of Surgical Research, Research Institute, Osaka, Japan.

UI MeSH Term Description Entries
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II

Related Publications

M Sada, and M Hashimoto, and Y Ichikawa, and T Kaneshige, and S Nakamura, and S Suzuki, and K Uchida, and T Fukunishi, and H Amemiya
Importance of HLA-DRB1 molecular matching between recipient and donor in cadaveric renal transplantation.
June 1996, Transplantation proceedings,
M Sada, and M Hashimoto, and Y Ichikawa, and T Kaneshige, and S Nakamura, and S Suzuki, and K Uchida, and T Fukunishi, and H Amemiya
Clinical value of HLA-DRB1 typing in cadaveric renal transplantation.
December 1993, Transplantation proceedings,
M Sada, and M Hashimoto, and Y Ichikawa, and T Kaneshige, and S Nakamura, and S Suzuki, and K Uchida, and T Fukunishi, and H Amemiya
HLA-DRB1 matching as a recipient selection criterion in cadaveric renal transplantation.
June 1993, Transplantation,
M Sada, and M Hashimoto, and Y Ichikawa, and T Kaneshige, and S Nakamura, and S Suzuki, and K Uchida, and T Fukunishi, and H Amemiya
High resolution HLA-DRB1 SSP typing for cadaveric donor transplantation.
January 1995, Tissue antigens,
M Sada, and M Hashimoto, and Y Ichikawa, and T Kaneshige, and S Nakamura, and S Suzuki, and K Uchida, and T Fukunishi, and H Amemiya
The importance of class I and class II HLA in cadaveric renal transplantation.
April 1991, Clinical and investigative medicine. Medecine clinique et experimentale,
M Sada, and M Hashimoto, and Y Ichikawa, and T Kaneshige, and S Nakamura, and S Suzuki, and K Uchida, and T Fukunishi, and H Amemiya
HLA-DR matching in cadaveric renal transplantation.
February 1981, The New England journal of medicine,
M Sada, and M Hashimoto, and Y Ichikawa, and T Kaneshige, and S Nakamura, and S Suzuki, and K Uchida, and T Fukunishi, and H Amemiya
HLA-DQ matching in cadaveric renal transplantation.
October 1997, Clinical transplantation,
M Sada, and M Hashimoto, and Y Ichikawa, and T Kaneshige, and S Nakamura, and S Suzuki, and K Uchida, and T Fukunishi, and H Amemiya
Molecular compatibility and renal graft survival--the HLA DRB1 genotyping.
February 1993, Transplantation,
M Sada, and M Hashimoto, and Y Ichikawa, and T Kaneshige, and S Nakamura, and S Suzuki, and K Uchida, and T Fukunishi, and H Amemiya
Importance of minimizing HLA-DR mismatch and cold preservation time in cadaveric renal transplantation.
March 1996, Transplantation,
M Sada, and M Hashimoto, and Y Ichikawa, and T Kaneshige, and S Nakamura, and S Suzuki, and K Uchida, and T Fukunishi, and H Amemiya
HLA-DRB1 genotyping in Italian migraine patients.
January 2006, Neuroscience letters,
Copied contents to your clipboard!